This statistic shows the commercial expenses of the French pharmaceutical group Ipsen from 2014 to 2019 in million euros. The group spent more than 838 million euros in commercial expenses in 2019. It was more than the previous years.
Commercial expenses of the French pharmaceutical group Ipsen from 2014 to 2019 (in million euros)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Total equity of the Ipsen group 2014-2019
- Premium Statistic Global revenue in general medicine of the Ipsen group 2014-2019
- Premium Statistic Total liabilities of the Ipsen group 2014-2019
- Premium Statistic Total assets of the Ipsen group 2014-2019
- Premium Statistic Global revenue in specialty medicine of the Ipsen group 2014-2019
- Premium Statistic Global revenue of the Ipsen group 2019, by geographical area
- Premium Statistic Research and development expenditure of the Ipsen group 2014-2019
- Premium Statistic Operating profit of the Ipsen group 2014-2019
- Premium Statistic Consolidated net profit of the Ipsen group 2014-2019
- Premium Statistic Global revenue of the Ipsen group 2014-2019
About the region
10
- Basic Statistic Ipsen group sales 2019, by therapeutic area
- Basic Statistic Medication sales of the Ipsen Group 2019
- Premium Statistic Top global companies by orphan drug revenues 2023
- Basic Statistic Orphan drug sales worldwide by therapy category 2028
- Basic Statistic Orphan vs. non-orphan pipeline sales forecast worldwide 2023-2028
- Basic Statistic Worldwide Rx drug sales excluding generics and orphan drugs 2012-2026
- Premium Statistic Orphan vs. non-orphan drugs median cost per patient per year 2014-2018
- Premium Statistic Merck & Co.'s top-selling drugs 2023
- Basic Statistic Merck & Co total assets 2009-2023
- Basic Statistic SG&A expenses of Syneos Health 2013-2022
Selected statistics
5
- Premium Statistic Expenditure worldwide on diabetes by market 2013-2018
- Premium Statistic Medicinal market growth worldwide including rebates 2009-2018
- Basic Statistic AstraZeneca's revenue from top product Pulmicort 2006-2023
- Premium Statistic Chinese insulin market distribution: leading companies 2011
- Premium Statistic U.S. insulin market distribution: leading companies 2011
Other regions
10
- Basic Statistic Top U.S. oncology products by revenue in 2016
- Premium Statistic Revenue from pharmaceutical manufacturer in Denmark 2009-2023
- Premium Statistic R&D expenses of selected Chinese pharma companies 2021-2022
- Premium Statistic Italy: number of R&D employees of biotech pharma companies 2014-2017
- Basic Statistic Top pharmaceutical companies in Sweden by sales 2022
- Premium Statistic Biopharmaceutical market size forecast Japan 2011-2020
- Basic Statistic Antibacterials for systemic use: consumption in Luxembourg 2022
- Premium Statistic Revenue value from biotechnology companies in Germany 2008-2022
- Premium Statistic R&D spending ratio of JW Pharmaceutical South Korea 2014-2022
- Basic Statistic Alliances U.S. and Europe biotech companies by total potential value 2022
Related statistics
10
- Basic Statistic Number of employees of pharmaceutical companies by region France 2020
- Premium Statistic Revenue of the top ten pharmaceutical companies in France 2021
- Premium Statistic Number of companies in the pharmaceutical industry in France 1970-2018
- Basic Statistic Total revenue of the French drug market worldwide 2010-2018
- Basic Statistic Breakdown of employees of drug companies by age France 2014
- Premium Statistic Personnel costs of Boiron laboratories 2012-2022
- Premium Statistic Cashflow of Boiron laboratories 2013-2022
- Premium Statistic Boiron laboratories' market capitalization at the end of the year 2012-2022
- Premium Statistic Boiron's capital breakdown at the end of 2022, by shareholder
- Premium Statistic Workforce of Boiron laboratories in the World in 2022, by region
Further related statistics
10
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co cash dividends declared 2006-2023
- Sanofi's total assets 2007-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Celgene's revenue and net income 2006-2018
- M&A capacities - changes for the global pharma industry 2008-2015
- Revenue of Sinopharm 2011-2022, by category
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- GSK's operating profit by division 2006-2021
- Pfizer's ad spending 2006-2023
Further Content: You might find this interesting as well
Statistics
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co cash dividends declared 2006-2023
- Sanofi's total assets 2007-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Celgene's revenue and net income 2006-2018
- M&A capacities - changes for the global pharma industry 2008-2015
- Revenue of Sinopharm 2011-2022, by category
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- GSK's operating profit by division 2006-2021
- Pfizer's ad spending 2006-2023
Ipsen. (February 13, 2020). Commercial expenses of the French pharmaceutical group Ipsen from 2014 to 2019 (in million euros) [Graph]. In Statista. Retrieved May 04, 2024, from https://www.statista.com/statistics/1072766/ipsen-commercial-expenses-french-company/
Ipsen. "Commercial expenses of the French pharmaceutical group Ipsen from 2014 to 2019 (in million euros)." Chart. February 13, 2020. Statista. Accessed May 04, 2024. https://www.statista.com/statistics/1072766/ipsen-commercial-expenses-french-company/
Ipsen. (2020). Commercial expenses of the French pharmaceutical group Ipsen from 2014 to 2019 (in million euros). Statista. Statista Inc.. Accessed: May 04, 2024. https://www.statista.com/statistics/1072766/ipsen-commercial-expenses-french-company/
Ipsen. "Commercial Expenses of The French Pharmaceutical Group Ipsen from 2014 to 2019 (in Million Euros)." Statista, Statista Inc., 13 Feb 2020, https://www.statista.com/statistics/1072766/ipsen-commercial-expenses-french-company/
Ipsen, Commercial expenses of the French pharmaceutical group Ipsen from 2014 to 2019 (in million euros) Statista, https://www.statista.com/statistics/1072766/ipsen-commercial-expenses-french-company/ (last visited May 04, 2024)
Commercial expenses of the French pharmaceutical group Ipsen from 2014 to 2019 (in million euros) [Graph], Ipsen, February 13, 2020. [Online]. Available: https://www.statista.com/statistics/1072766/ipsen-commercial-expenses-french-company/